APA (7th ed.) Citation

Polhemus, D. J., Li, Z., Pattillo, C. B., Gojon, G., Gojon, G., Giordano, T., & Krum, H. (2015). A Novel Hydrogen Sulfide Prodrug, SG1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients. Cardiovascular therapeutics, 33(4), 216-226. https://doi.org/10.1111/1755-5922.12128

Chicago Style (17th ed.) Citation

Polhemus, David J., Zhen Li, Christopher B. Pattillo, Gabriel Gojon, Gabriel Gojon, Tony Giordano, and Henry Krum. "A Novel Hydrogen Sulfide Prodrug, SG1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients." Cardiovascular Therapeutics 33, no. 4 (2015): 216-226. https://doi.org/10.1111/1755-5922.12128.

MLA (9th ed.) Citation

Polhemus, David J., et al. "A Novel Hydrogen Sulfide Prodrug, SG1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients." Cardiovascular Therapeutics, vol. 33, no. 4, 2015, pp. 216-226, https://doi.org/10.1111/1755-5922.12128.